Multisystemic Convergence in Advanced HIV Disease without Antiretroviral Therapy: Enteroperitoneal Tuberculosis, Neurotoxoplasmosis, Intestinal Polyparasitism, and Highly Suspected Gastric Oncologic Lesion
DOI:
https://doi.org/10.70409/rmhhut.v19i2.172Keywords:
neurogenic diabetes insipidus, opportunistic infections, intestinal polyparasitism, acquired immunodeficiency syndrome, gastrointestinal tuberculosis, cerebral toxoplasmosis, HIVAbstract
Advanced HIV disease without antiretroviral therapy (ART) can trigger a fulminant multisystemic convergence of opportunistic infections that challenge conventional diagnostic paradigms. We report the case of an ART-naive 28-year-old male with a de novo HIV diagnosis (stage C3) and profound cachexia who initially presented with an exophytic Borrmann type I gastric lesion carrying a high oncological suspicion. However, histopathological analysis revealed an inflammatory-granulomatous process consistent with enteroperitoneal tuberculosis (confirmed via stool GeneXpert testing), coexisting with intestinal polyparasitism by Cryptosporidium spp., Giardia lamblia, and Blastocystis hominis. During his clinical course, the patient experienced a rapid neurological decline—manifested as akinetic mutism and neuroparesis—secondary to probable multifocal neurotoxoplasmosis. This central nervous system injury, with probable involvement of the hypothalamic nuclei, triggered an unusual central diabetes insipidus characterized by massive polyuria (5,020 mL/24h) and refractory dehydration. Due to the active central nervous system infection, ART initiation was mandatorily deferred. Despite targeted antimicrobial and antituberculous regimens, the patient progressed to mixed shock and irreversible multiorgan failure. This case highlights the extremes of immunological vulnerability, emphasizing the critical need for rapid molecular diagnostics and vigilant monitoring for atypical, highly lethal neuroendocrine complications.
References
UNAIDS. Global HIV & AIDS statistics — Fact sheet [Internet]. Ginebra: UNAIDS; 2026 [citado 4 de junio de 2026]. Disponible en: https://www.unaids.org/en/resources/fact-sheet
Soh QR, Oh LY, Chow EP, Johnson CC, Jamil MS, Ong JJ. HIV Testing Uptake According to Opt-In, Opt-Out or Risk-Based Testing Approaches: a Systematic Review and Meta-Analysis. Curr HIV/AIDS Rep. 2022;19(5):375–83. https://doi.org/10.1007/s11904-022-00614-0
World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring [Internet]. Ginebra: WHO; 2021 [citado 4 de junio de 2026]. Disponible en: https://www.who.int/publications/i/item/9789240031593
European AIDS Clinical Society (EACS). EACS Guidelines [Internet]. Bruselas: EACS; 2026 [citado 4 de junio de 2026]. Disponible en: https://www.eacsociety.org/guidelines/eacs-guidelines/
National Institutes of Health (NIH). Adult and Adolescent OIs HIV Clinical Guidelines [Internet]. Bethesda: NIH; 2026 [citado 4 de junio de 2026]. Disponible en: https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/whats-new
Bello CT, Santos FS, Duarte JS, Vasconcelos C. Diabetes insipidus and hypopituitarism in HIV: an unexpected cause. Endocrinol Diabetes Metab Case Rep. 2017;2017(1):17-0024. https://doi.org/10.1530/EDM-17-0024
Zaldívar-López A, Hernández-Romano PA, Infanzón-Ruiz R, Bravo-Sarmiento E, Torres-Hernández RM, López-Balderas NA. Prevalencia de Cryptosporidium spp., Cystoisospora belli y Cyclospora cayetanensis en pacientes infectados con VIH en el municipio de Veracruz, México. Rev Biomed. 2023;34(3):287–95.
Lengongo JVK, Ngondza BP, Ditombi BM, M'Bondoukwé NP, Ngomo JMN, Delis AM, et al. Prevalence and associated factors of intestinal parasite infection by HIV infection status among asymptomatic adults in rural Gabon. Afr Health Sci. 2020;20(3):1024–34. https://doi.org/10.4314/ahs.v20i3.5
Jin F, Vajdic CM, Poynten IM, McGee-Avila JK, Castle PE, Grulich AE. Cancer risk in people living with HIV and solid organ transplant recipients: a systematic review and meta-analysis. Lancet Oncol. 2024;25(7):933–44. https://doi.org/10.1016/S1470-2045(24)00189-X
Spalding VA, Fellenstein BA, Ahodantin J, Jeyarajan AJ, Wang Y, Khan SK, et al. YAP mediates HIV-related liver fibrosis. JHEP Rep. 2024;6(11):101163. https://doi.org/10.1016/j.jhepr.2024.101163
Suba M-I, Hogea B, Abu-Awwad A, Gurgus D, Folescu R, Timircan M-O, et al. Systemic inflammation and gastrointestinal complications in HIV patients: A cross-sectional study. Pathogens. 2025;14(1):34. https://doi.org/10.3390/pathogens14010034
Ma S, Chen X, Lai Y. Global research landscape of HIV and Kaposi's sarcoma: a visualized bibliometric analysis. Front Microbiol. 2025;16:1601245. https://doi.org/10.3389/fmicb.2025.1601245
Gaona Lerea MB, Benítez Estigarribia G, Cardozo MA, Almirón D. Características clínico-epidemiológicas de toxoplasmosis en sistema nervioso central de pacientes con VIH. Rev Inst Med Trop. 2024;19(2):44–50.
Garg RK, Pandey S, Agarwal M, Singhal S. Movement disorders in toxoplasmosis: A systematic review. Tremor Other Hyperkinet Mov (N Y). 2025;15:48. https://doi.org/10.5334/tohm.1093
Ramos MEH, Villaraza SG. The use of azithromycin and pyrimethamine for treatment of cerebral toxoplasmosis in HIV-infected patients: a systematic review. Encephalitis. 2023;3(2):64–70. https://doi.org/10.47936/encephalitis.2022.00115
Wandurraga Sánchez EA, Morales Camacho WJ, Plata Ortiz JE. Panhipopituitarismo y diabetes insípida central como primera manifestación de linfoma primario del sistema nervioso central. RevACE. 2017;3(1):43–6.
Warda F, Patel J, Shahla L. Pituitary abscess causing hypopituitarism in a patient with acquired immunodeficiency syndrome. AACE Clin Case Rep. 2022;8(6):243–6. https://doi.org/10.1016/j.aace.2022.08.002
Divala TH, Lewis J, Bulterys MA, Lutje V, Corbett EL, Schumacher SG, et al. Missed opportunities for diagnosis and treatment in patients with TB symptoms: a systematic review. Public Health Action. 2022;12(1):10–7. https://doi.org/10.5588/pha.21.0022
Zhang L, Ma W, Qiu Z, Kuang T, Wang K, Hu B, et al. Prognostic nutritional index as a prognostic biomarker for gastrointestinal cancer patients treated with immune checkpoint inhibitors. Front Immunol. 2023;14:1219929. https://doi.org/10.3389/fimmu.2023.1219929
Fazzini B, Märkl T, Costas C, Blobner M, Schaller SJ, Prowle J, et al. The rate and assessment of muscle wasting during critical illness: a systematic review and meta-analysis. Crit Care. 2023;27(1):2. https://doi.org/10.1186/s13054-022-04253-0.
Published
How to Cite
Conference Proceedings Volume
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.


